3 days popular7 days popular1 month popular3 months popular

Cook Medical Launches Hemospray™ – A Hemostatic Spray For The Treatment Of Nonvariceal Upper Gastrointestinal (GI) Bleeds, UK

has chosen the annual meeting of the British Society of Gastroenterology (BSG) to introduce an innovative endoscopic spray for use in nonvariceal bleeds in the to the UK market. Hemospray, which has undergone a clinical study and multiple evaluations[1], expands ’s current line of haemostasis devices, achieving haemostasis with a proprietary inorganic powder. It is now available to clinicians in the United Kingdom.

Hemospray is a single-use device, delivered through the channel of an endoscope and sprayed toward the source of a bleed. When the powder comes in contact with blood, it absorbs water and forms a gel, which acts both cohesively and adhesively to create a stable mechanical barrier that adheres to and covers the bleeding site. It is a nonthermal, nontraumatic treatment modality for achieving haemostasis.

“Hemospray is an important and new therapy, which offers an additional treatment option for patients who suffer from bleeding lesions in the upper GI tract,” said Dr. John Morris, consultant gastroenterologist at the Glasgow Royal Infirmary Hospital.

Current hemostasis therapies rely on thermal, mechanical or injection devices. These devices carry risks of damage to the surrounding tissue and also require that the device be precisely placed on the bleeding vessel. Hemospray is designed to minimize the risks associated with current therapies and without the precision required of other treatment modalities.

“Because these bleeds can be complicated, no treatment option represents the perfect solution, even Hemospray,” said Barry Slowey, vice president and global business leader for Cook Medical’s Endoscopy division. “However, we do feel that this new device gives clinicians another important tool for the care of their patients.”

A study conducted by lead investigators Prof. Joseph Sung and Dr. Sam Giday at the Chinese University of Hong Kong showed that Hemospray achieves acute hemostasis in peptic ulcers.[2] Further clinical studies are currently being conducted with Hemospray across multiple sites in Canada, Europe, and Hong Kong. The results of these studies will be available in the coming months.

For doctors wishing to use Hemospray at their hospital, training can be provided at over 20 centres countrywide in the UK. To reserve a place on an upcoming course please contact your local Cook representative.

Source

Early Clinical Experience of the Safety and Effectiveness of Hemospray in Achieving Hemostasis in Patients with Acute Peptic Ulcer Bleeding Endoscopy 2011; 43: 291-295

A hemostatic spray: The easy way out for upper gastrointestinal bleeding? Endoscopy 2011; 43: 343-344

Safety Analysis of Hemostatic Powder (Hemospray™) in a Porcine Model of Gastric Bleeding. Volume 75, No. 4S: 2012: AB228

Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI haemorrhage: preliminary experience (Barkun, AN et al) GASTROINTESTINAL ENDOSCOPY Volume 75, No. 6: 2012: p1278

Hemospray for Non-Variceal Upper Gastrointestinal Bleeding: Results of the Seal Dataset (Survey to Evaluate the Application of Hemospray in the Luminal Tract) GASTROINTESTINAL ENDOSCOPY Volume 75, No. 5: 2012: AB133

Emerging technologies for endoscopic hemostasis. GASTROINTESTINAL ENDOSCOPY Volume 75, No. 5: 2012: p933

[1] See list of references above.

[2] Sung JJ, Luo D, Wu JC, et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy. 2011;43(4):291-295.

Cook Medical